Related Experiment Video
Updated: Aug 14, 2026

An In Vivo Mouse Model of Total Intravenous Anesthesia During Cancer Resection Surgery
Published on: June 8, 2021
[Stereotaxy during intravenous anesthesia with propofol]
M Fukuda1, S Kameyama, T Kawaguchi
1Department of Neurosurgery, National Nishi-Niigata Chuo Hospital, Japan.
Abstract:
A series of 30 patients, who underwent stereotactic surgery for movement disorder under intravenous propofol anesthesia between March, 1995 and December, 1997, was retrospectively reviewed. In 28 patients with Parkinson's disease including seven juvenile cases of parkinsonism, the postoperative motor and ADL scores on the Unified Parkinson's Disease Rating Scale significantly improved. In the other two patients, one of whom had severe posttraumatic tremor and the other had cerebral palsy, the stereotactic surgery produced considerable alleviation of their symptoms. We evaluated and discussed the usefulness of intravenous propofol anesthesia in stereotaxy. Except for one patient who had an allergic reaction against propofol, none of the patients complained of intraoperative pain postoperatively. Wake-up tests were performed to record neural noise levels in 26 cases. This recording was performed under propofol anesthesia in two cases with advanced Parkinson's disease and one with cerebral palsy. In these patients, neural noise levels were recorded and were useful for identifying the target. Although the tremor disappeared under propofol anesthesia in 17 patients presenting with moderate or severe tremor, it was presented again after discontinuation of propofol. Wake-up test, therefore, made a good evaluation of Vim thalamotomy for tremor. In juvenile parkinsonian patients, three presented with dopa-induced dyskinesia (DID) during propofol infusion. In two of them, the DID emerged immediately after posteroventral pallidotomy and continued 4 or 10 hours after stereotaxy. These findings suggest that propofol possibly has an anti-parkinsonian effect. Intravenous propofol anesthesia is a useful method to use with stereotactic surgery for movement disorders.
Insights
Intravenous propofol anesthesia is effective for stereotactic surgery in movement disorders, improving patient outcomes and aiding target identification. This method offers pain relief and potential anti-parkinsonian effects, enhancing surgical precision.
Area of Science:
- Neurosurgery
- Anesthesiology
- Neurology
Context:
- Stereotactic surgery is a key treatment for movement disorders.
- Intravenous propofol anesthesia is increasingly used in neurosurgery.
- Evaluating anesthetic techniques is crucial for patient safety and surgical success.
Purpose:
- To assess the efficacy and safety of intravenous propofol anesthesia during stereotactic surgery for movement disorders.
- To evaluate the impact of propofol on patient outcomes, including motor function and activities of daily living (ADL).
- To determine the utility of propofol anesthesia in wake-up tests for neural noise recording and target identification.
Summary:
- A retrospective review of 30 patients undergoing stereotactic surgery for movement disorders under propofol anesthesia showed significant improvements in motor and ADL scores for Parkinson's disease patients.
- Propofol anesthesia facilitated wake-up tests for neural noise recording, aiding target identification, and tremor suppression in 17 patients.
- Adverse events were minimal, with one allergic reaction; however, three juvenile parkinsonian patients experienced dopa-induced dyskinesia (DID) during propofol infusion, suggesting a potential anti-parkinsonian effect.
Impact:
- Intravenous propofol anesthesia is a safe and effective anesthetic method for stereotactic surgery in movement disorders.
- Propofol facilitates intraoperative monitoring and potentially offers therapeutic benefits for Parkinson's disease symptoms.
- The findings support the continued use of propofol in stereotactic neurosurgery, optimizing patient care and surgical outcomes.

